- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oral Proteins and Peptides refer to biological drugs of peptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids with peptide chains. It is also an intermediate product of protein hydrolysis. N polypeptide chains are twisted and tangled according to a certain spatial structure to form a protein. Hydrolysis of macromolecular proteins produces peptides. Oral Proteins and Peptides are biochemical preparations, which require relatively strict storage and transportation environments.
The global Oral Proteins and Peptides market report provided by Global Market Monitor provides a detailed overview of the changes in the industry's market dynamics, and in-depth analysis of market segments by type and application. This report calculates the historical, current and projected market size by volume and value, and predicts recent industry trends and developments. This report describes in detail the current competitive landscape of the Oral Proteins and Peptides market, major competitors, and the product strategies that practitioners should adopt. This report shows practitioners the market segments and regions with growth potential, and shows their economic conditions, such as major regions, item values, profits, restrictions, power generation, supply, demand, and market development speed. The report also provides additional SWOT analysis, speculative accessibility research and risk-reward research.
In recent years, due to the increase in the prevalence of chronic diseases, the increase of patients' preference for oral drugs, and the increase of patients' dependence on patients, the global market's demand for Oral Proteins and Peptides has increased significantly. Secondly, the global aging degree is getting worse and the elderly population is increasing rapidly, which to a certain extent will promote the growth of the Oral Proteins and Peptides market. In addition, the government has spent more energy improving the medical environment, which is a valuable market opportunity for practitioners. However, the production cost of Oral Proteins and Peptides is extremely high, and the bioavailability of these drugs in the body is extremely low. These factors limit the growth of the market. In terms of market trends, the increase in R&D funding of pharmaceutical companies and the surge in purchasing power of emerging economies provide market participants with lucrative opportunities.
This report elaborates on the current development of the Oral Proteins and Peptides industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
ZydusCadilla Healthcare
Sanofi-Aventis LLC
Novartis AG
Abbott Laboratories
Johnson & Johnson
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
Application:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Oral Proteins and Peptides Industry Overview
-
1.1.1 Oral Proteins and Peptides Market Scope and Market Segments
-
1.1.2 Oral Proteins and Peptides Industry Characteristics
-
1.1.3 Global and China Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Oral Proteins and Peptides Production Value and Growth Rate (2017-2028)
-
1.2 Global Oral Proteins and Peptides Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Linaclotide
-
1.2.2 Plecanatide
-
1.2.3 Calcitonin
-
1.2.4 Insulin
-
1.2.5 Octreotide
-
1.3 Global Oral Proteins and Peptides Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Gastric & Digestive Disorders
-
1.3.2 Bone Diseases
-
1.3.3 Diabetes
-
1.3.4 Hormonal Disorders
-
1.4 Market Analysis by Region
-
1.4.1 North America Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Oral Proteins and Peptides Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Oral Proteins and Peptides Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Oral Proteins and Peptides Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Oral Proteins and Peptides Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Oral Proteins and Peptides Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Oral Proteins and Peptides Industry Porter's Five Forces Model Analysis
-
2.2.3 Oral Proteins and Peptides Industry PEST Analysis
-
2.3 Oral Proteins and Peptides Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Oral Proteins and Peptides Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Oral Proteins and Peptides Industry
Chapter 3 Global and China Oral Proteins and Peptides Market, by Manufacturer
-
3.1 Global and China Oral Proteins and Peptides Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Oral Proteins and Peptides Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Oral Proteins and Peptides Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Oral Proteins and Peptides Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Oral Proteins and Peptides Market Top 3 Players
Chapter 4 Global and China Oral Proteins and Peptides Market, by Type (2017-2028)
-
4.1 Oral Proteins and Peptides Market Trend, by Type
-
4.2 Global Oral Proteins and Peptides Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Oral Proteins and Peptides Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Oral Proteins and Peptides Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Oral Proteins and Peptides Price Trend, by Type (2017-2028)
-
4.3 China Oral Proteins and Peptides Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Oral Proteins and Peptides Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Oral Proteins and Peptides Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Oral Proteins and Peptides Price Trend, by Type (2017-2028)
Chapter 5 Global and China Oral Proteins and Peptides Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Oral Proteins and Peptides Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Oral Proteins and Peptides Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Oral Proteins and Peptides Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Oral Proteins and Peptides Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Oral Proteins and Peptides Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Oral Proteins and Peptides Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Oral Proteins and Peptides Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Oral Proteins and Peptides Market Analysis
-
7.1 North America Oral Proteins and Peptides Market, by Type
-
7.2 North America Oral Proteins and Peptides Market, by Application
-
7.3 North America Oral Proteins and Peptides Market Analysis and Forecast, by Country
-
7.3.1 United States Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Oral Proteins and Peptides Market Analysis
-
8.1 Europe Oral Proteins and Peptides Market, by Type
-
8.2 Europe Oral Proteins and Peptides Market, by Application
-
8.3 Europe Oral Proteins and Peptides Market Analysis and Forecast, by Country
-
8.3.1 Germany Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Oral Proteins and Peptides Market Analysis
-
9.1 APAC Oral Proteins and Peptides Market, by Type
-
9.2 APAC Oral Proteins and Peptides Market, by Application
-
9.3 APAC Oral Proteins and Peptides Market Analysis and Forecast, by Country
-
9.3.1 China Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Oral Proteins and Peptides Market Analysis
-
10.1 Latin America, Middle East and Africa Oral Proteins and Peptides Market, by Type
-
10.2 Latin America, Middle East and Africa Oral Proteins and Peptides Market, by Application
-
10.3 Latin America, Middle East and Africa Oral Proteins and Peptides Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Oral Proteins and Peptides Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Oral Proteins and Peptides Company Profiles
-
11.1 ZydusCadilla Healthcare
-
11.1.1 ZydusCadilla Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 ZydusCadilla Healthcare Oral Proteins and Peptides Product Profiles, Application and Specification
-
11.1.3 ZydusCadilla Healthcare Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sanofi-Aventis LLC
-
11.2.1 Sanofi-Aventis LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sanofi-Aventis LLC Oral Proteins and Peptides Product Profiles, Application and Specification
-
11.2.3 Sanofi-Aventis LLC Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Novartis AG
-
11.3.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Novartis AG Oral Proteins and Peptides Product Profiles, Application and Specification
-
11.3.3 Novartis AG Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Abbott Laboratories
-
11.4.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Abbott Laboratories Oral Proteins and Peptides Product Profiles, Application and Specification
-
11.4.3 Abbott Laboratories Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Johnson & Johnson
-
11.5.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Johnson & Johnson Oral Proteins and Peptides Product Profiles, Application and Specification
-
11.5.3 Johnson & Johnson Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Oral Proteins and Peptides Industry Investment Prospect and Risk Assessment
-
12.1 Oral Proteins and Peptides Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Oral Proteins and Peptides Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Global Oral Proteins and Peptides Production Value and Growth Rate (2017-2028)
-
Figure China Oral Proteins and Peptides Production Value and Growth Rate (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Linaclotide (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Plecanatide (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Calcitonin (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Insulin (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Octreotide (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Gastric & Digestive Disorders (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Bone Diseases (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Diabetes (2017-2028)
-
Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Hormonal Disorders (2017-2028)
-
Figure North America Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Oral Proteins and Peptides Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Oral Proteins and Peptides Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Oral Proteins and Peptides Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Oral Proteins and Peptides Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Oral Proteins and Peptides Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Oral Proteins and Peptides Market Share, by Manufacturer in 2021
-
Figure Global and China Oral Proteins and Peptides Market Share, by Manufacturer in 2022
-
Table Global Oral Proteins and Peptides Sales Volume, by Type (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Figure Global Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Value, by Type (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Value Share, by Type (2017-2028)
-
Figure Global Oral Proteins and Peptides Price Trend, by Type (2017-2028)
-
Table China Oral Proteins and Peptides Sales Volume, by Type (2017-2028)
-
Table China Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Table China Oral Proteins and Peptides Sales Value, by Type (2017-2028)
-
Table China Oral Proteins and Peptides Sales Value Share, by Type (2017-2028)
-
Figure China Oral Proteins and Peptides Price Trend, by Type (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Volume, by Application (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure Global Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Value, by Application (2017-2028)
-
Table Global Oral Proteins and Peptides Sales Value Share, by Application (2017-2028)
-
Figure Global Oral Proteins and Peptides Sales Value Share, by Application (2017-2028)
-
Table China Oral Proteins and Peptides Sales Volume, by Application (2017-2028)
-
Table China Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Table China Oral Proteins and Peptides Sales Value, by Application (2017-2028)
-
Table China Oral Proteins and Peptides Sales Value Share, by Application (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Value Share, by Application (2017-2028)
-
Figure China Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
Figure North America Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Oral Proteins and Peptides Production, Import, Consumption and Export (2017-2022)
-
Table North America Oral Proteins and Peptides Sales Volume, by Type (2017-2028)
-
Table North America Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Figure North America Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Table North America Oral Proteins and Peptides Sales Volume, by Application (2017-2028)
-
Table North America Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure North America Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure United States Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure United States Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Canada Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Table Europe Oral Proteins and Peptides Sales Volume, by Type (2017-2028)
-
Table Europe Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Figure Europe Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Table Europe Oral Proteins and Peptides Sales Volume, by Application (2017-2028)
-
Table Europe Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure Europe Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure Germany Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure UK Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure UK Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure France Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure France Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Italy Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Spain Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Poland Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Russia Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Table APAC Oral Proteins and Peptides Sales Volume, by Type (2017-2028)
-
Table APAC Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Figure APAC Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Table APAC Oral Proteins and Peptides Sales Volume, by Application (2017-2028)
-
Table APAC Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure APAC Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure China Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Japan Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure India Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure India Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Oral Proteins and Peptides Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Oral Proteins and Peptides Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oral Proteins and Peptides Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Oral Proteins and Peptides Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Oral Proteins and Peptides Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Oral Proteins and Peptides Sales Value and Growth Rate (2017-2028)
-
Table ZydusCadilla Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ZydusCadilla Healthcare Product Profiles, Application and Specification
-
Table ZydusCadilla Healthcare Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi-Aventis LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi-Aventis LLC Product Profiles, Application and Specification
-
Table Sanofi-Aventis LLC Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abbott Laboratories Product Profiles, Application and Specification
-
Table Abbott Laboratories Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Oral Proteins and Peptides Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-

Chinese